rs752311785
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001130144.3(LTBP3):c.751G>A(p.Glu251Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000171 in 1,561,526 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001130144.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LTBP3 | NM_001130144.3 | c.751G>A | p.Glu251Lys | missense_variant | 3/28 | ENST00000301873.11 | NP_001123616.1 | |
LTBP3 | NM_021070.4 | c.751G>A | p.Glu251Lys | missense_variant | 3/27 | NP_066548.2 | ||
LTBP3 | NM_001164266.1 | c.400G>A | p.Glu134Lys | missense_variant | 3/27 | NP_001157738.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LTBP3 | ENST00000301873.11 | c.751G>A | p.Glu251Lys | missense_variant | 3/28 | 2 | NM_001130144.3 | ENSP00000301873 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000119 AC: 18AN: 151768Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000960 AC: 16AN: 166588Hom.: 0 AF XY: 0.0000876 AC XY: 8AN XY: 91352
GnomAD4 exome AF: 0.000177 AC: 249AN: 1409758Hom.: 0 Cov.: 34 AF XY: 0.000168 AC XY: 117AN XY: 698106
GnomAD4 genome AF: 0.000119 AC: 18AN: 151768Hom.: 0 Cov.: 31 AF XY: 0.0000270 AC XY: 2AN XY: 74084
ClinVar
Submissions by phenotype
Brachyolmia-amelogenesis imperfecta syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 09, 2023 | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 251 of the LTBP3 protein (p.Glu251Lys). This variant is present in population databases (rs752311785, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with LTBP3-related conditions. ClinVar contains an entry for this variant (Variation ID: 571639). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2022 | The c.751G>A (p.E251K) alteration is located in exon 3 (coding exon 3) of the LTBP3 gene. This alteration results from a G to A substitution at nucleotide position 751, causing the glutamic acid (E) at amino acid position 251 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at